Quantinno Capital Management LP Harmony Biosciences Holdings, Inc. Transaction History
Quantinno Capital Management LP
- $22.5 Billion
- Q2 2025
A detailed history of Quantinno Capital Management LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Quantinno Capital Management LP holds 8,990 shares of HRMY stock, worth $233,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,990Holding current value
$233,919% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
289Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$172 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$152 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$133 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$42.4 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$41.2 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.54B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...